首页> 外文OA文献 >PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES

【2h】

PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES

机译：PND21与美国早期帕金森氏病的其他一线治疗方案相比，雷沙吉兰的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Farkouh R; Wilson MR; Tarrants ML; Castelli-Haley J; Armand C;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial [J] . C. M. Sackley, C. Rick, P. Au, Trials . 2020,第1期

机译：多中心，随机对照试验，用于比较Lee Silverman语音治疗的临床和成本效益与标准NHS语言治疗与帕金森病的语言治疗：随机对照试验的研究方案
2. Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain. [J] . Weinreb O, Amit T, Sagi Y, Journal of neural transmission . 2009,第11期

机译：基因组和蛋白质组学研究，用于研究抗帕金森氏病药物雷沙吉兰和司来吉兰在大鼠中脑中的作用机理。
3. Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson’s disease drug, rasagiline compared with selegiline, in the rat midbrain [J] . Orly Weinreb, Tamar Amit, Yotam Sagi, Journal of Neural Transmission . 2009,第11期

机译：基因组和蛋白质组学研究，在大鼠中脑中研究抗帕金森氏病药物雷沙吉兰和司来吉兰的作用机理
4. Near-infrared Light as a Possible Treatment Option for Parkinson's Disease and Laser Eye Injury [C] . DeSmet Kristina, Buchmann Ellen, Henry Michele, Mechanisms for low-light therapy IV . 2009

机译：近红外光可作为帕金森氏病和激光眼损伤的治疗选择
5. A Markov model simulation of neurodegenerative Parkinson's disease and cost-effectiveness analysis of pharmacotherapy and deep brain stimulation treatment [D] . Quock, Tiffany Puisanne 2008

机译：神经变性帕金森氏病的马尔可夫模型模拟以及药物治疗和深部脑刺激治疗的成本效益分析
6. A multicentre randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial [O] . C. M. Sackley, C. Rick, P. Au, 2020

机译：一项多中心随机对照试验用于比较Lee Silverman语音治疗与标准NHS言语和语言疗法与帕金森病对照的临床和成本效益：一项随机对照试验的研究方案
7. PND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES [O] . Farkouh R, Wilson MR, Tarrants ML, 2009

机译：PND12在美国早期帕金森病的治疗中雷沙吉兰抗罗哌尼洛的延缓释放左旋多巴的成本效益

PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES

著录项

引文网络

相似文献

相关主题

期刊订阅